Search results for: 'microfluid cell separation'
- Related search terms
- Cell+and+gene+manufacturing
- cell biolog research market global 2024 2030
- cell biolog research market global 2030 2024
- cell biolog research market global 2030 2025
- cell biolog research market global 2025 2030
-
22 Sep 2022  |  North America  |  Market Research
AI Commercial Use Cases, Impact Analyses, and Growth Opportunities in Clinical Genomics
Integration of Clinical Genomics and AI will lead to definitive Transformational Growth in the Next Decade
Clinical genomics regained significance during the pandemic with the development of the mRNA COVID-19 vaccine, and several non-invasive at-home test kits; an unprecedented feat in recent times. Genomics will take center stage, as large genome sequencing and research will continuously create data for new therapeutics. Artificial Intelligence (AI) an...
$2,450.00 -
14 Sep 2020  |  North America  |  Market Research
Smartphone-based Solutions Spur the Global Infectious Disease Point-of-Care Testing Market, Forecast to 2024
COVID-19 and STDs among Millennials Speed Development of Miniaturized POCT Devices and Alternate Care Sites to Enable Transformational Growth
The COVID-19 pandemic prompted a transformation in the infectious disease point-of-care testing (POCT) market. The shift towards miniaturized POCT devices will lead to the emergence of cost-effective integrated lab-on-a-chip devices based on microfluidic technologies and smartphone-based solutions enabling multiplexed detection of infectious pathog...
$4,950.00 -
12 Aug 2021  |  North America  |  Frost Radar
Frost Radar™: Non-Invasive Prenatal Testing, Global, 2021
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Non-invasive prenatal testing (NIPT) provides an alternative to invasive, higher-risk tests such as amniocentesis, requiring a maternal blood sample to obtain cell-free DNA from both mother and fetus for analysis. Since NIPTs debut in 2011, laboratories and testing companies have made incremental upgrades to their non-invasive screens, improving ac...
$4,950.00 -
30 Dec 2022  |  North America  |  Market Research
Trends and Growth Indicators for Physician Offices/labs in Decentralized Testing and Services
Personalized Diagnostics Are at the Cusp of Transformational Growth
Accelerated reforms due to COVID-19 and technologically advanced sample-in-answer-out portable, web-connected, encrypted devices that provide results in a few minutes changed the diagnostic healthcare industry. Decentralized testing empowers clinicians to make lifesaving decisions for the patient. It shortens supply chain lag time, saves costs of i...
$2,450.00 -
31 Jan 2020  |  North America  |  Market Research
Predictions for the Global Life Sciences Industry, 2020
COVID-19 Pandemic will Drive New Digital-tech Adoption in Drug Discovery and Testing Services, and Federal Funding will Encourage Stronger Product Pipelines
The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...
$1,500.00 -
22 Oct 2018  |  North America  |  Market Research
Global Life Sciences Instrumentation and Research Tools Market, Forecast to 2023
Digitalization and M&As to Transform the Current Competitive Structure of the Industry
The global life sciences instrumentation and research tools market is currently going through a transformation driven by ongoing market consolidation and technological innovation. Over the past five years, the industry has witnessed more than 50 mergers and acquisitions (M&A), which have resulted in a market consolidation at the top. Most of these ...
$4,950.00 -
20 Mar 2019  |  North America  |  Market Research
2019 Predictions of the Global Life Sciences Industry
As Novel Technologies Find Traction, Industry Focus Will Shift Towards Successful Monetization to Deliver Value-based Care
he global life science industry is in a state of flux. While the recent years have seen the advent of multiple novel technologies, such as in-vitro diagnostics (IVD), CRISPR-Cas9, virtual clinical trials, and liquid biopsy, the industry stands at a crossroad with challenges in scaling-up and commercializing such technologies. In addition, companies...
$1,500.00